InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
2
Disclosed sells
0
T+90 hit rate
43%
T+90 mean return
-16.7%
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Floyd Robert Michael, Chief Executive Officer. Officer active across 1 company, notably Processa Pharmaceuticals, Inc.. In total, 8 filings have been recorded. Breakdown: 2 buys · 0 sell. Total volume traded: €24k. Activity tracked since 22 June 2021. The latest transaction was filed on 9 February 2023 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations8 total
10,000 shares@ US$0.8024.1% of flowCommon StockSEC:0001567619-23-002404:0
12,500 sharesCommon StockSEC:0001567619-22-018383:0
7,000 shares0Common StockSEC:0001567619-22-016598:0
7,000 shares0Common StockSEC:0001567619-22-007993:0
12,500 sharesCommon StockSEC:0001567619-21-018171:0
12,500 sharesCommon StockSEC:0001567619-21-018171
2,000 shares@ US$7.029238.0% of flowCommon StockSEC:0001567619-21-012496
Ideal exit: 19 Mar 2022 (T+270)
2,000 shares@ US$7.02920.18% mcap50.0% of flowCommon StockSEC:0001567619-21-012496:0
Ideal exit: 19 Mar 2022 (T+270)
8 of 8 declarations
About Floyd Robert Michael
Robert Michael Floyd is the Chief Operating Officer at Processa Pharmaceuticals, Inc. He oversees the daily operations of the company, ensuring efficiency and compliance of processes. His role is essential in supporting the operational strategy and growth of Processa Pharmaceuticals, Inc.
